Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.39 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.39 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 4/20 | 0.35 |
| ▸ | PPARA | Q07869 | 4/20 | 0.35 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.35 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | METAP2 | P50579 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.33 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.33 |
| ▸ | TNF | P01375 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26415783 | 0.90 | AKR1C3 (0.39) | AKR1C3AKR1C2LIMK1CYP1A1CYP1B1 | |
| SCHEMBL26416362 | 0.85 | PARP14 (0.44) | AKR1C3AKR1C2ALOX5UGT2B7CRHR1 | |
| SCHEMBL26415777 | 0.83 | METAP2 (0.40) | AKR1C3AKR1C2LIMK1CYP1A1CYP1B1 | |
| SCHEMBL26415764 | 0.79 | AKR1C3 (0.39) | AKR1C3AKR1C2CYP1A1CYP1B1PPARG | |
| SCHEMBL27049991 | 0.77 | CYP1A1 (0.55) | LIMK1CYP1A1CYP1B1MCL1ALOX5 | |
| SCHEMBL4549340 | 0.76 | ALOX5 (0.49) | S1PR4S1PR5ALOX5 | |
| SCHEMBL26415741 | 0.75 | PARP14 (0.44) | AKR1C3AKR1C2ALOX5AKR1B1UGT2B7 | |
| SCHEMBL26415756 | 0.75 | AKR1C3 (0.37) | AKR1C3AKR1C2AKR1B1UGT2B7CRHR1 | |
| SCHEMBL22174862 | 0.75 | HSD17B1 (0.45) | LIMK1CYP1A1CYP1B1S1PR4S1PR5 | |
| SCHEMBL431447 | 0.74 | LIMK1 (0.54) | LIMK1CYP1A1CYP1B1MCL1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230130537-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230130537-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230130537-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR THE SAME | MAOA, MAOB, AOC2 | AKR1C3 4042/4885AKR1C2 3289/4885LIMK1 478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.